Close Menu

NEW YORK (GenomeWeb) — Cancer Genetics today reported a 7 percent increase in its second quarter revenues driven by its biopharma and discovery services units.

For the three-month period ended June 30, CGI's revenues rose to $7.0 million from $6.6 million in the same quarter last year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.